The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib (O) + ceralasertib (C) in patients (pts) with metastatic triple-negative breast cancer (mTNBC): Translational analysis of the VIOLETTE trial.
 
Natalia Lukashchuk
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kevin Punie
Honoraria - AstraZeneca; Exact Sciences; Focus Patient; Gilead Sciences; Gilead Sciences (Inst); Lilly; Lilly (Inst); Lilly (Inst); MSD; MSD (Inst); Mundipharma (Inst); Novartis; Novartis (Inst); Novartis (Inst); Pfizer; Pfizer; Pfizer (Inst); Pfizer (Inst); Roche; Roche (Inst); Seagen; Seagen (Inst)
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca (Inst); Exact Sciences; Gilead Sciences; Lilly; Lilly (Inst); Lilly (Inst); MSD (Inst); Novartis; Novartis; Novartis; Novartis; Novartis; Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer; Pierre Fabre (Inst); Roche; Roche (Inst); Roche (Inst); Roche (Inst); Sanofi; Seagen; Teva (Inst); Vifor Pharma (Inst)
Research Funding - MSD (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche; Roche; Roche; Roche
Other Relationship - Need
 
Zbigniew Nowecki
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Anne C. Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
Consulting or Advisory Role - Gilead Sciences; MSD
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; MSD Oncology; Novartis
 
William Jacot
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Eisai; Lilly O.; MSD; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Eisai; Lilly O.; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca Canada; Daiichi Sankyo Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
 
Jee Hyun Kim
Honoraria - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche; Roche; Sanofi
Consulting or Advisory Role - Bixink; Daiichi Sankyo/Astra Zeneca; Eisai; Everest Medicine; MSD; Roche; Yuhan
Research Funding - Eisai (Inst); Ono Pharmaceutical (Inst); Roche (Inst)
 
Marc A. Webster
Consulting or Advisory Role - AstraZeneca Canada; Genomic Health; Gilead Sciences; Knight Pharmaceuticals; Merck; Roche Canada; Seattle Genetics/Astellas
 
Judith Balmaña
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - European patent request submitted (EP17382884.9) not related to this work
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca (Inst); Besins Healthcare (Inst); Gilead Sciences (Inst); Rappta Therapeutics (Inst); Sanofi (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis (Inst); Pfizer
 
Ed Casson
Consulting or Advisory Role - AstraZeneca
 
Bienvenu Loembe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Emma Dean
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca (I); AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca
 
Joshua Armenia
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Andrew NJ Tutt
Employment - Institute of Cancer Research
Leadership - Institute of Cancer Research
Stock and Other Ownership Interests - InBiomotion
Honoraria - PAGE Therapeutics (Inst)
Consulting or Advisory Role - American College of Independent Medical Examiners (Inst); AstraZeneca; AstraZeneca; Cancer Panels; EM Partners; GE Healthcare (Inst); Gilead Sciences; Gilead Sciences (Inst); MD Anderson Cancer Center; Merck Serono (Inst); Research to Practice; VJOncology (Inst)
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck KGaA (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - I have i the past and may in the future be in Receipt of payments under my employer (ICR London) Rewards to inventors Scheme associated with patents held by ICR associated with the use of PARP inhibitors in BRCA 1/2 deficient cancers
Expert Testimony - National Institute for Health and Clinical Excellence (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Breast Cancer Now Charity (Inst); Cancer Research UK (Inst)
(OPTIONAL) Uncompensated Relationships - St Gallen Early Breast Cancer Consensus Conference